329 related articles for article (PubMed ID: 16849583)
1. Hic-5/ARA55, a LIM domain-containing nuclear receptor coactivator expressed in prostate stromal cells.
Heitzer MD; DeFranco DB
Cancer Res; 2006 Jul; 66(14):7326-33. PubMed ID: 16849583
[TBL] [Abstract][Full Text] [Related]
2. Hic-5/ARA55: a prostate stroma-specific AR coactivator.
Heitzer MD; DeFranco DB
Steroids; 2007 Feb; 72(2):218-20. PubMed ID: 17166536
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of action of Hic-5/androgen receptor activator 55, a LIM domain-containing nuclear receptor coactivator.
Heitzer MD; DeFranco DB
Mol Endocrinol; 2006 Jan; 20(1):56-64. PubMed ID: 16141357
[TBL] [Abstract][Full Text] [Related]
4. Epithelial Hic-5/ARA55 expression contributes to prostate tumorigenesis and castrate responsiveness.
Li X; Martinez-Ferrer M; Botta V; Uwamariya C; Banerjee J; Bhowmick NA
Oncogene; 2011 Jan; 30(2):167-77. PubMed ID: 20818421
[TBL] [Abstract][Full Text] [Related]
5. Distinct LIM domains of Hic-5/ARA55 are required for nuclear matrix targeting and glucocorticoid receptor binding and coactivation.
Guerrero-Santoro J; Yang L; Stallcup MR; DeFranco DB
J Cell Biochem; 2004 Jul; 92(4):810-9. PubMed ID: 15211577
[TBL] [Abstract][Full Text] [Related]
6. Expression of androgen receptor associated protein 55 (ARA55) in the developing human fetal prostate.
Cai G; Huang H; Shapiro E; Zhou H; Yeh S; Melamed J; Greco MA; Lee P
J Urol; 2005 Jun; 173(6):2190-3. PubMed ID: 15879885
[TBL] [Abstract][Full Text] [Related]
7. Stromal-epithelial cell interactions and androgen receptor-coregulator recruitment is altered in the tissue microenvironment of prostate cancer.
Cano P; Godoy A; Escamilla R; Dhir R; Onate SA
Cancer Res; 2007 Jan; 67(2):511-9. PubMed ID: 17234758
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer cells increase androgen sensitivity by increase in nuclear androgen receptor and androgen receptor coactivators; a possible mechanism of hormone-resistance of prostate cancer cells.
Fujimoto N; Miyamoto H; Mizokami A; Harada S; Nomura M; Ueta Y; Sasaguri T; Matsumoto T
Cancer Invest; 2007 Feb; 25(1):32-7. PubMed ID: 17364555
[TBL] [Abstract][Full Text] [Related]
9. The Group 3 LIM domain protein paxillin potentiates androgen receptor transactivation in prostate cancer cell lines.
Kasai M; Guerrero-Santoro J; Friedman R; Leman ES; Getzenberg RH; DeFranco DB
Cancer Res; 2003 Aug; 63(16):4927-35. PubMed ID: 12941817
[TBL] [Abstract][Full Text] [Related]
10. Expression of androgen receptor coactivators in normal and cancer prostate tissues and cultured cell lines.
Mestayer C; Blanchère M; Jaubert F; Dufour B; Mowszowicz I
Prostate; 2003 Aug; 56(3):192-200. PubMed ID: 12772188
[TBL] [Abstract][Full Text] [Related]
11. Prosaposin is an AR-target gene and its neurotrophic domain upregulates AR expression and activity in prostate stromal cells.
Koochekpour S; Lee TJ; Sun Y; Hu S; Grabowski GA; Liu Z; Garay J
J Cell Biochem; 2008 Aug; 104(6):2272-85. PubMed ID: 18481277
[TBL] [Abstract][Full Text] [Related]
12. Androgen and prostatic stroma.
Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
[TBL] [Abstract][Full Text] [Related]
13. Aging up-regulates ARA55 in stromal cells, inducing androgen-mediated prostate cancer cell proliferation and migration.
Zou Q; Cui D; Liang S; Xia S; Jing Y; Han B
J Mol Histol; 2016 Jun; 47(3):305-15. PubMed ID: 27178620
[TBL] [Abstract][Full Text] [Related]
14. Androgen induction of the androgen receptor coactivator four and a half LIM domain protein-2: evidence for a role for serum response factor in prostate cancer.
Heemers HV; Regan KM; Dehm SM; Tindall DJ
Cancer Res; 2007 Nov; 67(21):10592-9. PubMed ID: 17975004
[TBL] [Abstract][Full Text] [Related]
15. Control of androgen receptor signaling in prostate cancer by the cochaperone small glutamine rich tetratricopeptide repeat containing protein alpha.
Buchanan G; Ricciardelli C; Harris JM; Prescott J; Yu ZC; Jia L; Butler LM; Marshall VR; Scher HI; Gerald WL; Coetzee GA; Tilley WD
Cancer Res; 2007 Oct; 67(20):10087-96. PubMed ID: 17942943
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of androgen receptor associated coregulators in prostate cancer cells.
Sampson ER; Yeh SY; Chang HC; Tsai MY; Wang X; Ting HJ; Chang C
J Biol Regul Homeost Agents; 2001; 15(2):123-9. PubMed ID: 11501969
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor levels are increased by interferons in human prostate stromal and epithelial cells.
Basrawala Z; Alimirah F; Xin H; Mohideen N; Campbell SC; Flanigan RC; Choubey D
Oncogene; 2006 May; 25(19):2812-7. PubMed ID: 16331249
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
[TBL] [Abstract][Full Text] [Related]
19. Expression of AR associated protein 55 (ARA55) and androgen receptor in prostate cancer.
Miyoshi Y; Ishiguro H; Uemura H; Fujinami K; Miyamoto H; Miyoshi Y; Kitamura H; Kubota Y
Prostate; 2003 Sep; 56(4):280-6. PubMed ID: 12858356
[TBL] [Abstract][Full Text] [Related]
20. Regulation of rat prostate stromal cell myodifferentiation by androgen and TGF-beta1.
Gerdes MJ; Larsen M; Dang TD; Ressler SJ; Tuxhorn JA; Rowley DR
Prostate; 2004 Feb; 58(3):299-307. PubMed ID: 14743470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
